Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes.

The ideal nanoscale drug delivery vehicle allows control over the released dose in space and time. We demonstrate that this can be achieved by stealth liposomes comprising self-assembled superparamagnetic iron oxide nanoparticles (NPs) individually stabilized with palmityl-nitroDOPA incorporated in the lipid membrane. Alternating magnetic fields were used to control timing and dose of repeatedly released cargo from such vesicles by locally heating the membrane, which changed its permeability without major effects on the environment.

[1]  Horst Vogel,et al.  An integrated self-assembled nanofluidic system for controlled biological chemistries. , 2008, Angewandte Chemie.

[2]  Kyoung Taek Kim,et al.  Smart nanocontainers and nanoreactors. , 2010, Nanoscale.

[3]  G. Bothun,et al.  Hepatoma cell uptake of cationic multifluorescent quantum dot liposomes. , 2009, The journal of physical chemistry. B.

[4]  Timo Laaksonen,et al.  Gold nanoparticles enable selective light-induced contents release from liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[5]  H. Kyu Pak,et al.  Interfacial energy consideration in the organization of a quantum dot–lipid mixed system , 2008 .

[6]  Christophe Danelon,et al.  Multifunctional lipid/quantum dot hybrid nanocontainers for controlled targeting of live cells. , 2006, Angewandte Chemie.

[7]  M. Textor,et al.  Influence of Electronegative Substituents on the Binding Affinity of Catechol-Derived Anchors to Fe3O4 Nanoparticles , 2011 .

[8]  Younan Xia,et al.  Gold nanocages: synthesis, properties, and applications. , 2008, Accounts of chemical research.

[9]  M. Dewhirst,et al.  The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. , 2001, Advanced drug delivery reviews.

[10]  L. Lo,et al.  Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release , 2009, Nanotechnology.

[11]  P. Cullis,et al.  Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[12]  B. D. Ladbrooke,et al.  Molecular interactions in mixed lecithin systems. , 1970, Biochimica et biophysica acta.

[13]  D. Uhríková,et al.  Bilayer thickness and lipid interface area in unilamellar extruded 1,2-diacylphosphatidylcholine liposomes: a small-angle neutron scattering study. , 2001, Biochimica et biophysica acta.

[14]  Vladimir P. Torchilin,et al.  Liposomes as ‘smart’ pharmaceutical nanocarriers , 2010 .

[15]  K. Jacobson,et al.  Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. , 1973, Biochimica et biophysica acta.

[16]  V. Ginzburg,et al.  Modeling the thermodynamics of the interaction of nanoparticles with cell membranes. , 2007, Nano letters.

[17]  W. Binder,et al.  Guiding the location of nanoparticles into vesicular structures: a morphological study. , 2007, Physical chemistry chemical physics : PCCP.

[18]  R Blumenthal,et al.  Design of liposomes for enhanced local release of drugs by hyperthermia. , 1978, Science.

[19]  T. McIntosh,et al.  Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol). , 1995, Biophysical journal.

[20]  M. Textor,et al.  A detailed investigation of the formation kinetics and layer structure of poly(ethylene glycol) tether supported lipid bilayers , 2009 .

[21]  Marcus Textor,et al.  Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups. , 2009, Nano letters.

[22]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[23]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[24]  Pallab Pradhan,et al.  Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[25]  K. Nicolay,et al.  Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. , 2006, Bioconjugate chemistry.

[26]  J. Schellens,et al.  Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma , 2004, Cancer Chemotherapy and Pharmacology.

[27]  Norio Tada,et al.  A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. , 2009, Nature nanotechnology.

[28]  P. Babinec,et al.  AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy. , 2002, Bioelectrochemistry.

[29]  K. Krishnan Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy , 2010, IEEE Transactions on Magnetics.

[30]  Theresa M. Allen,et al.  Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors , 2005, Clinical Cancer Research.

[31]  Jordi Arbiol,et al.  Hydrophobic gold nanoparticle self-assembly with phosphatidylcholine lipid: membrane-loaded and janus vesicles. , 2010, Nano letters.

[32]  Rona Chandrawati,et al.  A microreactor with thousands of subcompartments: enzyme-loaded liposomes within polymer capsules. , 2009, Angewandte Chemie.

[33]  Yanjing Chen,et al.  Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating. , 2010, ACS nano.